BenevolentAI: From Machine Learning Startup towards New Drug Producer
BenevolentAI is using machine learning to gather insights from the body of pharmaceutical literature in order to produce new potential drugs, but can it keep top talent?
img:is([sizes=auto i],[sizes^="auto," i]){contain-intrinsic-size:3000px 1500px} /*# sourceURL=wp-img-auto-sizes-contain-inline-css */
BenevolentAI is using machine learning to gather insights from the body of pharmaceutical literature in order to produce new potential drugs, but can it keep top talent?